Skip to main content
Livermore
Livermore
ZHEN

Redmile Group, LLC

SEC CIK
0001425738
Latest filing
Aug 14, 2026

Holdings in Q3 2024

Holdings as of Sep 30, 2024, filed Nov 14, 2024. Long positions only; changes compare share counts with Q2 2024.

Institution overview
Positions
63
0 vs. Q2 2024
Portfolio value
$1.70B
+$43.5M (+2.6%) vs. Q2 2024
Filed
Nov 14, 2024
SEC
Holdings of Redmile Group, LLC in Q3 2024
SecurityClassSharesValue% of portfolioShare changeActionHistory
HOOKHOOKIPA Pharma Inc.COM106,376$457.4K<0.1%00.0%UnchangedConverted for a 1-for-10 splitHistory
ADAPYAdaptimmune Therapeutics PLCSPONDS ADR715,607$680.1K<0.1%00.0%UnchangedHistory
RAPTRAPT Therapeutics, Inc.COM504,532$1.01M0.1%−32,150−6.0%ReducedHistory
KLRSKalaris Therapeutics, Inc.COM1,907,969$1.54M0.1%00.0%UnchangedHistory
Achilles Therapeutics PLC00449L102SPONSORED ADS1,608,089$1.64M0.1%00.0%Unchanged–
ALLKAllakos Inc.COM3,077,828$2.01M0.1%00.0%UnchangedHistory
CABACabaletta Bio, Inc.COM442,826$2.09M0.1%00.0%UnchangedHistory
PENPenumbra IncCOM13,847$2.69M0.2%+13,847NewHistory
GRTSGritstone bio, Inc.COM4,920,178$2.85M0.2%−187,554−3.7%ReducedHistory
XERSXeris Biopharma Holdings, Inc.COM1,046,587$2.98M0.2%00.0%UnchangedHistory
IVVDInvivyd, Inc.COM3,065,714$3.13M0.2%00.0%UnchangedHistory
ATXSAstria Therapeutics, Inc.COM310,884$3.42M0.2%+310,884NewHistory
LVTXLAVA Therapeutics NVSHS2,074,372$3.44M0.2%00.0%UnchangedHistory
BOLDBoundless Bio, Inc.COM1,023,548$3.55M0.2%−11,035−1.1%ReducedHistory
ATRAAtara Biotherapeutics, Inc.COM NEW452,270$3.68M0.2%00.0%UnchangedHistory
STXSStereotaxis, Inc.COM NEW2,108,219$4.30M0.3%00.0%UnchangedHistory
VTYXVentyx Biosciences, Inc.COM2,107,215$4.59M0.3%−56,911−2.6%ReducedHistory
CYTKCytokinetics IncCOM NEW97,116$5.13M0.3%−14,751−13.2%ReducedHistory
ACIUAC Immune SASHS1,694,167$6.40M0.4%−113,537−6.3%ReducedHistory
RPTXRepare Therapeutics Inc.COM1,942,555$6.68M0.4%00.0%UnchangedHistory
VERVVerve Therapeutics, Inc.COM1,383,366$6.70M0.4%−80,040−5.5%ReducedHistory
NUVBNuvation Bio Inc.COM CL A3,031,009$6.94M0.4%00.0%UnchangedHistory
ALXOAlx Oncology Holdings IncCOM3,836,576$6.98M0.4%−199,875−5.0%ReducedHistory
PRMEPrime Medicine, Inc.COM2,074,350$8.03M0.5%00.0%UnchangedHistory
ORKAOruka Therapeutics, Inc.COM411,728$10.1M0.6%+411,728NewHistory
ESTAEstablishment Labs Holdings Inc.COM261,803$11.3M0.7%+48,779+22.9%AddedHistory
ARDXArdelyx, Inc.COM1,660,763$11.4M0.7%−220,738−11.7%ReducedHistory
ETNB89bio, Inc.COM1,569,850$11.6M0.7%−175,806−10.1%ReducedHistory
SYKStryker CorpStock32,741$11.8M0.7%−6,742−17.1%ReducedHistory
ISRGIntuitive Surgical IncCOM NEW26,698$13.1M0.8%−13,145−33.0%ReducedHistory
FDMT4D Molecular Therapeutics, Inc.COM1,262,090$13.6M0.8%+188,655+17.6%AddedHistory
IMVTImmunovant, Inc.COM642,229$18.3M1.1%−77,948−10.8%ReducedHistory
BNTXBioNTech SESPONSORED ADS154,456$18.3M1.1%+154,456NewHistory
STTKShattuck Labs, Inc.COM5,615,489$19.6M1.2%00.0%UnchangedHistory
IDYAIDEAYA Biosciences, Inc.COM681,150$21.6M1.3%−78,366−10.3%ReducedHistory
CLDXCelldex Therapeutics, Inc.COM NEW657,175$22.3M1.3%−61,548−8.6%ReducedHistory
BSXBoston Scientific CorpStock330,873$27.7M1.6%−59,380−15.2%ReducedHistory
ABSIAbsci CorpCOM8,253,316$31.5M1.9%00.0%UnchangedHistory
KROSKeros Therapeutics, Inc.COM552,506$32.1M1.9%00.0%UnchangedHistory
SLNSilence Therapeutics plcADS1,899,317$34.5M2.0%−114,979−5.7%ReducedHistory
PLRXPliant Therapeutics, Inc.COM3,197,491$35.8M2.1%−12,100−0.4%ReducedHistory
CTLTCatalent, Inc.COM595,570$36.1M2.1%00.0%UnchangedHistory
ANNXAnnexon, Inc.COM6,427,462$38.1M2.2%00.0%UnchangedHistory
AUGXAugmedix, Inc.COM16,380,327$38.5M2.3%00.0%UnchangedHistory
BEAMBeam Therapeutics Inc.COM1,611,013$39.5M2.3%−92,048−5.4%ReducedHistory
AKROAkero Therapeutics, Inc.COM1,387,479$39.8M2.3%−226,994−14.1%ReducedHistory
NGNENeurogene Inc.COM964,347$40.5M2.4%−49,316−4.9%ReducedHistory
SRRKScholar Rock Holding CorpCOM5,238,837$42.0M2.5%−214,246−3.9%ReducedHistory
LIVNLivaNova PLCSHS875,039$46.0M2.7%−54,467−5.9%ReducedHistory
FATEFate Therapeutics IncCOM13,169,057$46.1M2.7%00.0%UnchangedHistory
COGTCogent Biosciences, Inc.COM4,484,380$48.4M2.9%−315,593−6.6%ReducedHistory
ADCTADC Therapeutics SASHS15,669,217$49.4M2.9%+400,000+2.6%AddedHistory
IGMSIGM Biosciences, Inc.COM3,072,478$50.8M3.0%00.0%UnchangedHistory
RGNXREGENXBIO Inc.COM4,892,902$51.3M3.0%+323,100+7.1%AddedHistory
BHVNBiohaven Ltd.COM1,034,219$51.7M3.0%−53,357−4.9%ReducedHistory
REPLReplimune Group, Inc.COM4,781,183$52.4M3.1%−780,913−14.0%ReducedHistory
STOKStoke Therapeutics, Inc.COM4,713,509$57.9M3.4%−7,545−0.2%ReducedHistory
ZYMEZymeworks Inc.COM5,101,911$64.0M3.8%−109,126−2.1%ReducedHistory
KYMRKymera Therapeutics, Inc.COM1,393,256$65.9M3.9%−186,019−11.8%ReducedHistory
IMNMImmunome Inc.COM4,889,554$71.5M4.2%00.0%UnchangedHistory
FOLDAmicus Therapeutics, Inc.COM8,246,592$88.1M5.2%−2,348,497−22.2%ReducedHistory
NRIXNurix Therapeutics, Inc.COM4,280,981$96.2M5.7%−142,635−3.2%ReducedHistory
KRYSKrystal Biotech, Inc.COM810,245$147.5M8.7%−210,833−20.6%ReducedHistory

Sold out since Q2 2024 (4)

Positions held at the end of Q2 2024 that are gone from this filing.

Positions of Redmile Group, LLC sold out since Q2 2024
SecurityClassShares in Q2 2024Value in Q2 2024% of portfolio in Q2 2024History
BPMCBlueprint Medicines CorpCOM94,405$10.2M0.6%History
TRDAEntrada Therapeutics, Inc.COM560,971$7.99M0.5%History
LABStandard Biotools Inc.COM411,631$728.6K<0.1%History
TKNOAlpha Teknova, Inc.COM154,509$211.7K<0.1%History